Clinical trial Recruiting at 1 site Observational Ages 18 and up

How deep brain stimulation affects thinking and memory in Parkinson's

Official title: A Neural Basis for Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study

Run by Medical University of South Carolina · NCT06960096 · Data updated 2026-11-12

This project will use MRI scans to see if subthalamic nucleus deep brain stimulation (DBS) changes brain networks and relates to thinking or memory declines in people with Parkinson's disease who already have DBS implants.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment55 (estimated)
SponsorMedical University of South Carolina
Academic / other
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedAugust 21, 2025
Main results expectedApril 1, 2028
Study endsApril 1, 2028
Registry record updatedOctober 8, 2026
Trial IDNCT06960096 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Parkinson's disease who previously received 3T‑compatible unilateral or bilateral STN‑DBS implants and completed a neurological and neuropsychological evaluation at MUSC are ideal candidates.

Probably not a fit

People without STN‑DBS, with non‑MRI‑compatible implants, severe claustrophobia, significant non‑PD neurological disease, or those who cannot safely undergo MRI are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will recruit 55 people with Parkinson's disease who have undergone 3T‑compatible unilateral or bilateral STN‑DBS at the Medical University of South Carolina. Participants will complete one visit for consent, demographic and cognitive testing and a second visit with DBS‑compatible MRI scanning while stimulation is turned ON and OFF to measure brain network connectivity. The team will compare functional connectivity and microstructural features to participants' cognitive performance to identify patterns linked to post‑DBS cognitive decline. The goal is to use these findings to refine which patients and stimulation targets are least likely to cause unwanted cognitive side effects.

Why it matters

Potential benefit: If successful, the findings could help doctors choose patients and stimulation targets that lower the risk of cognitive decline after STN‑DBS.

How similar studies have gone: Prior work has shown that DBS can alter cognitive performance and functional connectivity and that fMRI can detect network changes, but using ON/OFF DBS‑fMRI to directly link those changes to long‑term cognitive decline is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects above 18 years of age
* Individuals with a PD diagnosis as defined by the UK Brain Bank diagnostic criteria for Parkinson's disease (58) which have undergone a neurological and neuropsychological evaluation at MUSCs movement disorder center, and were selected to undergo 3T compatible unilateral or bilateral STN- DBS implants

Exclusion Criteria:

* Uncorrected visual or hearing impairments, as indicated by self-report
* Individuals who are pregnant or expect to become pregnant during the course of the study
* Individuals that have a history of neurological disease (other than PD) including previous stroke, major head trauma, and epilepsy or seizures.
* Individuals with claustrophobia, or the inability to lie supine position in the MRI scanner
* COPD with oxygen dependence
* Non-MRI compatible metal implants (surgical clips or staples, cardiac pacemakers etc.)

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Daniel Lench, PhD — Medical University of South Carolina
  • Study coordinator: Recruitment Coordinator
  • Email: malakout@musc.edu
  • Phone: 843-792-0235

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.